๐Ÿ‡บ๐Ÿ‡ธ US Earnings by TNBfolio
5.85K subscribers
49.2K photos
44.7K links
Download Telegram
#NMRA

Neumora Therapeutics Shares Decline After Q2 Results
https://finance.yahoo.com/news/neumora-therapeutics-shares-decline-q2-142611613.html

Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
https://finance.yahoo.com/news/neumora-therapeutics-reports-second-quarter-110000111.html

Needham Initiates Neumora Therapeutics With Buy Rating, $23 Price Target
https://finance.yahoo.com/news/needham-initiates-neumora-therapeutics-buy-122554705.html

Mizuho Securities Initiates Neumora Therapeutics at Outperform With $20 Price Target
https://finance.yahoo.com/news/mizuho-securities-initiates-neumora-therapeutics-100607966.html

10 clinical trials to watch in the second half of 2024
https://finance.yahoo.com/m/ed70d22b-e2bd-367b-835d-245c5361f651/10-clinical-trials-to-watch.html
OptimumBank Holdings, Inc. (OPHC)
์‹œ๊ฐ€์ด์•ก: 42.87M
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Major_Banks
์„นํ„ฐ: #Finance
ํ™ˆํŽ˜์ด์ง€: https://www.optimumbank.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 9.94M / -- / -- / 56.2% / --
2403: -- / -- / -- / -- / --
2312: 8.19M / -- / -- / -- / 20.0%
2309: 6.83M / -- / -- / -- / 7.2%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.34 / -- / -- / 88.9% / --
2403: -- / -- / -- / -- / --
2312: -- / -- / -- / -- / --
2309: 0.18 / -- / -- / -- / 0.0%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 27.16M(44.5%) / --(--)
2212: 18.8M(73.4%) / 0.68(-57.8%)
2112: 10.84M(105.1%) / 1.61(696.3%)
2012: 5.28M(--) / -0.27(53.4%)

#OPHC

- ์‚ฌ์—…์š”์•ฝ: OptimumBank Holdings, Inc. operates as the bank holding company for OptimumBank that provides various consumer and commercial banking services to individuals and businesses. It accepts demand interest-bearing and noninterest-bearing, savings, money market, and NOW accounts, as well as time deposits, wire transfers, ACH services, and certificates of deposit. The company also offers re...
CF Bankshares Inc. (CFBK)
์‹œ๊ฐ€์ด์•ก: 132.90M
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Major_Banks
์„นํ„ฐ: #Finance
ํ™ˆํŽ˜์ด์ง€: https://www.cf.bank

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 12.59M / 13.5M / -6.7% / 2.5% / 7.2%
2403: 11.74M / -- / -- / -11.6% / -7.4%
2312: 12.68M / -- / -- / -- / -1.1%
2309: 12.82M / -- / -- / -- / 4.4%
2306: 12.28M / -- / -- / -- / -7.6%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.65 / 0.54 / 20.4% / -1.5% / 38.3%
2403: 0.47 / -- / -- / -30.9% / -27.7%
2312: 0.65 / -- / -- / -- / 4.8%
2309: 0.62 / -- / -- / -- / -6.1%
2306: 0.66 / -- / -- / -- / -2.9%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 51.05M(-0.5%) / --(--)
2212: 51.31M(-3.8%) / 2.78(0.4%)
2112: 53.33M(-39.1%) / 2.77(-38.0%)
2012: 87.5M(--) / 4.47(120.2%)

#CFBK

- ์‚ฌ์—…์š”์•ฝ: CF Bankshares Inc. operates as the bank holding company for CFBank, National Association that provides various banking products and services in the United States. The company accepts savings, retail and business checking accounts, and money market accounts, as well as certificates of d...
Amgen Inc. (AMGN)
์‹œ๊ฐ€์ด์•ก: 176.45B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Biotechnology_Biological_Products_No_Diagnostic_Substances
์„นํ„ฐ: #Health_Care
ํ™ˆํŽ˜์ด์ง€: https://www.amgen.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 8.39B / 8.35B / 0.5% / 20.1% / 12.7%
2403: 7.45B / -- / -- / 22.0% / -9.1%
2312: 8.2B / -- / -- / -- / 18.7%
2309: 6.9B / -- / -- / -- / -1.2%
2306: 6.99B / -- / -- / -- / 14.4%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 4.97 / 4.98 / -0.2% / 93.4% / 2466.7%
2403: -0.21 / -- / -- / -104.0% / -114.8%
2312: 1.42 / -- / -- / -- / -55.9%
2309: 3.22 / -- / -- / -- / 25.3%
2306: 2.57 / -- / -- / -- / -51.3%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 28.19B(7.1%) / 12.49(3.1%)
2212: 26.32B(1.3%) / 12.11(17.8%)
2112: 25.98B(2.2%) / 10.28(-16.5%)
2012: 25.42B(--) / 12.31(--)

#AMGN

- ์‚ฌ์—…์š”์•ฝ: Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment o...
Airbnb, Inc. (ABNB)
์‹œ๊ฐ€์ด์•ก: 82.96B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Diversified_Commercial_Services
์„นํ„ฐ: #Finance
ํ™ˆํŽ˜์ด์ง€: https://www.airbnb.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 2.75B / 2.74B / 0.4% / 10.7% / 28.4%
2403: 2.14B / -- / -- / 17.8% / -3.4%
2312: 2.22B / -- / -- / -- / -34.7%
2309: 3.4B / -- / -- / -- / 36.8%
2306: 2.48B / -- / -- / -- / 36.6%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.86 / 0.91 / -5.5% / -12.2% / 109.8%
2403: 0.41 / -- / -- / 127.8% / 174.5%
2312: -0.55 / -- / -- / -- / -108.3%
2309: 6.63 / -- / -- / -- / 576.5%
2306: 0.98 / -- / -- / -- / 444.4%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 9.92B(18.1%) / 7.24(159.5%)
2212: 8.4B(40.2%) / 2.79(589.5%)
2112: 5.99B(77.4%) / -0.57(96.5%)
2012: 3.38B(--) / -16.12(--)

#ABNB

- ์‚ฌ์—…์š”์•ฝ: Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. The company's marketplace connects hosts and guests online or through mobile devices to book spaces and experiences. It primaril...
Coupang, Inc. (CPNG)
์‹œ๊ฐ€์ด์•ก: 37.32B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Catalog_Specialty_Distribution
์„นํ„ฐ: #Consumer_Discretionary
ํ™ˆํŽ˜์ด์ง€: https://www.aboutcoupang.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 7.32B / 7.4B / -1.1% / 25.4% / 2.9%
2403: 7.11B / -- / -- / 22.6% / 8.4%
2312: 6.56B / -- / -- / -- / 6.1%
2309: 6.18B / -- / -- / -- / 5.9%
2306: 5.84B / -- / -- / -- / 0.6%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.07 / -0.01 / 800.0% / -12.5% / 2440.8%
2403: 0.002755 / -- / -- / -94.5% / -99.5%
2312: 0.57 / -- / -- / -- / 1040.0%
2309: 0.05 / -- / -- / -- / -37.5%
2306: 0.08 / -- / -- / -- / 60.0%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 24.38B(18.5%) / 0.75(1600.0%)
2212: 20.58B(11.8%) / -0.05(95.4%)
2112: 18.41B(53.8%) / -1.08(-231.6%)
2012: 11.97B(--) / -0.325708(--)

#CPNG

- ์‚ฌ์—…์š”์•ฝ: Coupang, Inc., together with its subsidiaries owns and operates retail business through its mobile applications and Internet websites primarily in South Korea. The company operates through Product Commerce and Developing Offerings se...
Axon Enterprise, Inc. (AXON)
์‹œ๊ฐ€์ด์•ก: 22.21B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Ordnance_And_Accessories
์„นํ„ฐ: #Industrials
ํ™ˆํŽ˜์ด์ง€: https://www.axon.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 504M / 477.85M / 5.5% / 34.5% / 9.4%
2403: 460.74M / -- / -- / 34.3% / 6.6%
2312: 432.14M / -- / -- / -- / 4.5%
2309: 413.6M / -- / -- / -- / 10.4%
2306: 374.61M / -- / -- / -- / 9.2%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 1.2 / 1.02 / 17.6% / 650.0% / -30.6%
2403: 1.73 / -- / -- / 183.6% / 130.7%
2312: 0.75 / -- / -- / -- / -3.8%
2309: 0.78 / -- / -- / -- / 387.5%
2306: 0.16 / -- / -- / -- / -73.8%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 1.56B(31.4%) / 2.31(13.8%)
2212: 1.19B(37.8%) / 2.03(323.1%)
2112: 863.38M(26.8%) / -0.91(-2933.3%)
2012: 681.0M(--) / -0.03(--)

#AXON

- ์‚ฌ์—…์š”์•ฝ: Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and ...
Illumina, Inc. (ILMN)
์‹œ๊ฐ€์ด์•ก: 18.61B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Medical_Specialities
์„นํ„ฐ: #Health_Care
ํ™ˆํŽ˜์ด์ง€: https://www.illumina.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 1.11B / 1.09B / 1.8% / -5.6% / 3.2%
2403: 1.08B / -- / -- / -1.0% / -4.1%
2312: 1.12B / -- / -- / -- / 0.3%
2309: 1.12B / -- / -- / -- / -4.8%
2306: 1.18B / -- / -- / -- / 8.2%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.36 / 0.11 / 227.3% / 124.3% / 145.6%
2403: -0.79 / -- / -- / -4050.0% / 28.8%
2312: -1.11 / -- / -- / -- / 76.7%
2309: -4.77 / -- / -- / -- / -222.3%
2306: -1.48 / -- / -- / -- / -7500.0%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 4.5B(-1.7%) / -7.34(73.8%)
2212: 4.58B(1.3%) / -28.0(-655.6%)
2112: 4.53B(39.7%) / 5.04(13.3%)
2012: 3.24B(--) / 4.45(--)

#ILMN

- ์‚ฌ์—…์š”์•ฝ: Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based ...